CNO Stock Analysis: Buy, Sell, or Hold?
CNO - CNO Financial Group, Inc.
$54.79
-0.58 (-1.05%)
▼
5d:
+1.01%
30d:
-0.54%
90d:
+19.19%
BUY
MODERATE Confidence
Analysis Updated: Aug 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When CNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CNO shows positive signals but monitor for confirmation. Market pricing in 4.3% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: CNO shows positive signals but monitor for confirmation. Market pricing in 4.3% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$64.11
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$39.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNO is currently trading at $54.79, which is considered fair relative to its 30-day fair value range of $53.49 to $55.30. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.9) compared to its historical average (9.6). At these levels, the market is pricing in 4.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is approaching resistance at $55.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNO scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CNO is in a strong uptrend. The price is approaching resistance at $55.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNO scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$53.49 -
$55.30
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.75)
- NEUTRAL: Market pricing in 4.3% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 62/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$53.49 -
$55.30
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$52.83
Resistance Level
$55.70
Current Trend
Strong Uptrend
Technical data as of
Aug 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.90
Wall Street Target
$53.75
(-1.9%)
Revenue Growth (YoY)
11.6%
Earnings Growth (YoY)
46.2%
Profit Margin
6.0%
Valuation Premium vs History
+4.3% premium
PE vs Historical
10.9 vs 9.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.3%
(market-implied from PE analysis)
1-Year Target
$57.15
(+4%)
2-Year Target
$59.60
(+9%)
3-Year Target
$62.17
(+14%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$54.77
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.7%)
$126.13
(+130%)
Base:
(SPY PE: 10.9, Growth: 7.7%)
$68.38
(+25%)
Bear:
(PE: 9.3, Growth: 7.7%)
$58.12
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 19.03 | Current EPS (TTM): $2.91
Bull Case
$105.24
(+92%)
Analyst growth 72.8%, PE expands to 20.9
Base Case
$95.67
(+75%)
Market implied 72.8%, PE stable at 19.0
Bear Case
$37.65
(-31%)
Severe decline -20.0%, PE contracts to 16.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 31, 2026 7:29 PM ET
Data refreshes hourly during market hours. Next update: 8:29 PM
Data refreshes hourly during market hours. Next update: 8:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott L Goldberg
SELL
11060 shares
2026-03-19
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$105 | 46 HOLD |
|
UNM
Unum Group |
BUY
13 analysts |
$102 | 56 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 61 BUY |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$34 | 42 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
